The store will not work correctly when cookies are disabled.
1-(4-benzoylpiperazin-1-yl)-2-(naphthalen-1-yl)ethane-1,2-dione
ID: ALA4533962
PubChem CID: 5280312
Max Phase: Preclinical
Molecular Formula: C23H20N2O3
Molecular Weight: 372.42
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: O=C(C(=O)N1CCN(C(=O)c2ccccc2)CC1)c1cccc2ccccc12
Standard InChI: InChI=1S/C23H20N2O3/c26-21(20-12-6-10-17-7-4-5-11-19(17)20)23(28)25-15-13-24(14-16-25)22(27)18-8-2-1-3-9-18/h1-12H,13-16H2
Standard InChI Key: IZFXCOQJZCTIAK-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
6.5167 -8.6809 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8117 -9.0942 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.8194 -9.9071 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.5250 -10.3110 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2300 -9.8978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.2294 -9.0806 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.9344 -8.6674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.6448 -9.0713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9290 -7.8502 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.6463 -9.8882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3558 -10.2921 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0618 -9.8787 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.0537 -9.0574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.3436 -8.6572 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1144 -10.3204 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4040 -9.9165 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.1198 -11.1376 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6990 -10.3298 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.3986 -9.0993 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.9926 -9.9237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2881 -10.3363 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2930 -11.1543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7100 -11.1431 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0104 -11.5543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0176 -12.3640 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.7238 -12.7633 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4241 -12.3472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4133 -11.5389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
7 8 1 0
7 9 2 0
8 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 8 1 0
3 15 1 0
15 16 1 0
15 17 2 0
16 18 1 0
16 19 2 0
18 20 2 0
20 21 1 0
21 22 2 0
22 24 1 0
23 18 1 0
23 24 1 0
24 25 2 0
25 26 1 0
26 27 2 0
27 28 1 0
28 23 2 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 372.42 | Molecular Weight (Monoisotopic): 372.1474 | AlogP: 3.01 | #Rotatable Bonds: 3 |
Polar Surface Area: 57.69 | Molecular Species: NEUTRAL | HBA: 3 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: ┄ | CX LogP: 3.05 | CX LogD: 3.05 |
Aromatic Rings: 3 | Heavy Atoms: 28 | QED Weighted: 0.52 | Np Likeness Score: -1.02 |
References
1. Wang T, Wallace OB, Zhang Z, Fang H, Yang Z, Robinson BA, Spicer TP, Gong YF, Blair WS, Shi PY, Lin PF, Deshpande M, Meanwell NA, Kadow JF.. (2019) A survey of core replacements in indole-based HIV-1 attachment inhibitors., 29 (11): [PMID:30940396] [10.1016/j.bmcl.2019.03.018] |